Population
In vivo models of venous and arterial thrombosis in experimental animals and in vitro coagulation models
Design
Review
Authors
Loading...
Marine sulfated polysaccharides merit targeted development as heparin alternatives; leaves open clinical translation pending randomized trials.
Sulfated fucans and fucosylated chondroitin sulfate from marine sources demonstrate potent anticoagulant and antithrombotic activity, highlighting their potential as therapeutic alternatives to heparin.
Paulo A.S. Mourão (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: